NetworkNewsBreaks – Therma Bright, Inc. (TSX.V:

NetworkNewsBreaks – Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) Receives Pain Relief Device Prototype, Issues TherOZap Technology Update

Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) this morning announced receipt of its pain relief device prototype and provided an update on its TherOZap technology. Following introduction of the first design of its device for relief of general, arthritic or orthopedic pain in October, the company has rapidly advanced its development, received the prototype and identified a research group on which it will initiate efficacy tests. Therma Bright has also sent final prototypes of its TherOZap technology to a top research laboratory for testing of the technology against the Zika virus. “We are excited to announce these updates and will report the results of both technologies as they become available,” Therma Bright CEO Rob Fia stated in the news release. “As we diligently work to advance our technologies, our goal remains on strengthening our portfolio and pursuing new applications and opportunities.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer